1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell

Novavax (NVAX -0.98%) shares have offered investors a roller coaster ride over the past few years. They soared more than 2,700% in early pandemic days as investors bet on the company's investigational vaccine -- then plummeted 98% from their peak as the vaccine entered the market late, missing out on the biggest revenue opportunity.Today, the company is generating sales from its vaccine, but less than anticipated, and that's forced Novavax to realign its cost base with the revenue opportunity. The biotech l ...